• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression.

作者信息

Deschler D G, Osorio R, Ascher N L, Lee K C

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, USA.

出版信息

Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):1037-41. doi: 10.1001/archotol.1995.01890090073014.

DOI:10.1001/archotol.1995.01890090073014
PMID:7544136
Abstract

Posttransplantation lymphoproliferative disorder (PTLD) is a well-described complication of the systemic immunosuppression required for successful organ transplantation. Lesions of PTLD often occur in the region of the head and neck and require otolaryngologic evaluations. Although the majority of reported cases of PTLD are associated with cyclosporine immunosuppression, recently, PTLD has been described in patients treated solely with the newer systemic immunosuppressive agent tacrolimus (FK 506). As an introduction to tacrolimus and to PTLD as one of its complications, a case of PTLD presenting as airway obstruction in a child treated solely with tacrolimus immunosuppression is described. In addition, a review of tacrolimus and PTLD in patients under tacrolimus immunosuppression is presented to familiarize the otolaryngologist with this important new immunosuppressive agent and a potential complication of its use.

摘要

相似文献

1
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression.
Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):1037-41. doi: 10.1001/archotol.1995.01890090073014.
2
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.免疫抑制对小儿肝移植患者移植后淋巴细胞增生性疾病的影响。
Transplantation. 2000 Jul 15;70(1):94-9.
3
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.采用客观病例确诊法确定小儿肝移植受者中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病的危险因素。
Transplantation. 2003 Apr 15;75(7):987-93. doi: 10.1097/01.TP.0000057244.03192.BD.
4
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.小儿肝移植受者淋巴增殖性疾病的多种临床表现:单中心经验
Transplant Proc. 2010 Jun;42(5):1763-8. doi: 10.1016/j.transproceed.2010.01.077.
5
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.小儿肝移植中的移植后淋巴细胞增生性疾病。原发性EB病毒感染与免疫抑制之间的相互作用。
Transplantation. 1996 Aug 15;62(3):370-5. doi: 10.1097/00007890-199608150-00012.
6
FK 506 associated disorders in liver transplantation.肝移植中与FK 506相关的病症。
J Gastroenterol Hepatol. 1992 May-Jun;7(3):257-9. doi: 10.1111/j.1440-1746.1992.tb00975.x.
7
Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.小儿移植受者移植后淋巴细胞增生性疾病的合理管理。
J Pediatr Surg. 1999 Jan;34(1):112-5; discussion 115-6. doi: 10.1016/s0022-3468(99)90239-7.
8
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.接受他克莫司治疗的小儿肝移植受者中,与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病发病率增加的早期迹象和风险因素。
Transplantation. 1997 Nov 27;64(10):1438-42. doi: 10.1097/00007890-199711270-00011.
9
Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.活体肝移植术后婴儿中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病伴他克莫司代谢恶化
Transplantation. 2015 Jan;99(1):114-9. doi: 10.1097/TP.0000000000000255.
10
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.接受基于他克莫司免疫抑制治疗的肾移植儿童的爱泼斯坦-巴尔病毒相关疾病
Transplantation. 1999 Oct 15;68(7):997-1003. doi: 10.1097/00007890-199910150-00017.

引用本文的文献

1
Post-transplant lymphoproliferative disease of the larynx.喉移植后淋巴组织增生性疾病
J Surg Case Rep. 2019 Apr 6;2019(4):rjz111. doi: 10.1093/jscr/rjz111. eCollection 2019 Apr.
2
Epstein-barr virus-related post-transplant lymphoproliferative disorder in a renal transplant recipient treated with tacrolimus and antithymocyte globulin.一名接受他克莫司和抗胸腺细胞球蛋白治疗的肾移植受者发生的与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病
Clin Drug Investig. 2003;23(4):281-3. doi: 10.2165/00044011-200323040-00008.